Gene-Editing and RNA Interference in Treating Hepatitis B: A Review

Gene-Editing and RNA Interference in Treating Hepatitis B: A Review

The hepatitis B virus (HBV) continues to cause substantial health and economic burdens, and its target of elimination may not be reached in 2030 without further efforts in diagnostics, non-pharmaceutical prevention measures, vaccination, and treatment. Current therapeutic options in chronic HBV, bas...

Full description

Bibliographic Details
Main Authors: Nadiia Kasianchuk, Krystyna Dobrowolska, Sofiia Harkava, Andreea Bretcan, Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Robert Flisiak, Piotr Rzymski
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Viruses
Subjects:
hepatitis B
antivirals
CRISPR/Cas
TALENs
RNA interference
therapeutic vaccinations
Online Access:https://www.mdpi.com/1999-4915/15/12/2395

Internet

https://www.mdpi.com/1999-4915/15/12/2395

Similar Items